Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Noelia Martinez-Jánez"'
Autor:
Gilles Freyer, Noelia Martinez-Jañez, Bożena Kukielka-Budny, Malgorzata Ulanska, Hugues Bourgeois, Montserrat Muñoz, Serafin Morales, Juan Bayo Calero, Laura Cortesi, Tamás Pintér, Markéta Palácová, Nelli Cherciu, Edgar Petru, Johannes Ettl, Cécilia de Almeida, Gustavo Villanova, Romain Raymond, Christine Ta Thanh Minh, Ana Rodrigues, Marina E. Cazzaniga
Publikováno v:
Breast, Vol 74, Iss , Pp 103681- (2024)
Introduction: Single-agent oral vinorelbine is a standard of care for hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer (ABC) that has progressed on endocrine therapy. Metronomic administra
Externí odkaz:
https://doaj.org/article/0b574b9f1cb64611a2fd0d40a3bafcde
Autor:
Ariadna Tibau, M. Teresa Martínez, Manuel Ramos, Luis De La Cruz-Merino, Ana Santaballa, Miriam O’Connor, Noelia Martínez-Jañez, Fernando Moreno, Isaura Fernández, Juan Antonio Virizuela, Jesús Alarcón, Juan de La Haba-Rodríguez, Pedro Sánchez-Rovira, Cinta Rosa Albacar, Coralia Bueno Muiño, Catherine Kelly, Maribel Casas, Susana Bezares, Libertad Rosell, Joan Albanell
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: In the FLIPPER trial, palbociclib/fulvestrant significantly improved progression-free survival (PFS) compared with placebo/fulvestrant in postmenopausal women with HR+/HER2− advanced breast cancer (ABC). Objective: We assessed health-re
Externí odkaz:
https://doaj.org/article/4398b5e7e69c43578d588e0c150efdbd
Autor:
Lourdes Peña-Jaimes, Irene González-García, María Eugenia Reguero-Callejas, Ignacio Pinilla-Pagnon, Belén Pérez-Mies, Víctor Albarrán-Artahona, Noelia Martínez-Jañez, Juan Manuel Rosa-Rosa, José Palacios
Publikováno v:
Diagnostic Pathology, Vol 13, Iss 1, Pp 1-6 (2018)
Abstract Background Breast carcinoma with osteoclast-like giant cells (OGCs) is infrequent, being most reported cased described as ductal invasive carcinomas. Invasive pleomorphic lobular carcinoma (PLC) is a distinct morphological variant of invasiv
Externí odkaz:
https://doaj.org/article/696c89dabe454b669c9aee139f0bb6f6
Autor:
Ramon Colomer, Francisca Mulero, José Palacios, Eva Carrasco, Ruth Campo, María José Escudero, Antonio Lopez-Alonso, Alfredo Carrato, Sonia Pernas Simon, Fernando Moreno-Anton, Esther Zamora, Begoña Bermejo, Juan Guerra, Emilio Alba, Antonio Llombart-Cussac, Gemma Viñas, Raquel de Andres, Encarna Adrover, Antonio Gonzalez-Martin, Noelia Martinez-Jánez, Miguel Gil-Gil, José Angel García-Saenz, Javier Cortes, Isabel Calvo, Luis Manso, Ana Lluch, Miguel Quintela-Fandino
Table containing the inter-patient PET variability data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2921832c1bd5b9a029b91d45f1664f41
https://doi.org/10.1158/1078-0432.22463381
https://doi.org/10.1158/1078-0432.22463381
Autor:
Ramon Colomer, Francisca Mulero, José Palacios, Eva Carrasco, Ruth Campo, María José Escudero, Antonio Lopez-Alonso, Alfredo Carrato, Sonia Pernas Simon, Fernando Moreno-Anton, Esther Zamora, Begoña Bermejo, Juan Guerra, Emilio Alba, Antonio Llombart-Cussac, Gemma Viñas, Raquel de Andres, Encarna Adrover, Antonio Gonzalez-Martin, Noelia Martinez-Jánez, Miguel Gil-Gil, José Angel García-Saenz, Javier Cortes, Isabel Calvo, Luis Manso, Ana Lluch, Miguel Quintela-Fandino
CONSORT DIAGRAM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94013593e75979e63b97df5cbe7e9166
https://doi.org/10.1158/1078-0432.22463387
https://doi.org/10.1158/1078-0432.22463387
Autor:
Ramon Colomer, Francisca Mulero, José Palacios, Eva Carrasco, Ruth Campo, María José Escudero, Antonio Lopez-Alonso, Alfredo Carrato, Sonia Pernas Simon, Fernando Moreno-Anton, Esther Zamora, Begoña Bermejo, Juan Guerra, Emilio Alba, Antonio Llombart-Cussac, Gemma Viñas, Raquel de Andres, Encarna Adrover, Antonio Gonzalez-Martin, Noelia Martinez-Jánez, Miguel Gil-Gil, José Angel García-Saenz, Javier Cortes, Isabel Calvo, Luis Manso, Ana Lluch, Miguel Quintela-Fandino
Purpose: We previously detected promising efficacy of neoadjuvant nintedanib (a multityrosine kinase inhibitor, TKI) in early HER2-negative breast cancer. In a preclinical study, we monitored stromal hypoxia with 18F-fluoromisonidazole-positron emiss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f0ec11c3cac5902f38dfd563804ff22
https://doi.org/10.1158/1078-0432.c.6525386
https://doi.org/10.1158/1078-0432.c.6525386
Autor:
Ramon Colomer, Francisca Mulero, José Palacios, Eva Carrasco, Ruth Campo, María José Escudero, Antonio Lopez-Alonso, Alfredo Carrato, Sonia Pernas Simon, Fernando Moreno-Anton, Esther Zamora, Begoña Bermejo, Juan Guerra, Emilio Alba, Antonio Llombart-Cussac, Gemma Viñas, Raquel de Andres, Encarna Adrover, Antonio Gonzalez-Martin, Noelia Martinez-Jánez, Miguel Gil-Gil, José Angel García-Saenz, Javier Cortes, Isabel Calvo, Luis Manso, Ana Lluch, Miguel Quintela-Fandino
Figure S1 legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26830a81f452d9617c558d35b368709f
https://doi.org/10.1158/1078-0432.22463384.v1
https://doi.org/10.1158/1078-0432.22463384.v1
Autor:
Miguel J. Gil-Gil, Meritxell Bellet, Milana Bergamino, Serafín Morales, Agustí Barnadas, Luís Manso, Cristina Saura, Adela Fernández-Ortega, Elena Garcia-Martinez, Noelia Martinez-Jañez, Mireia Melé, Patricia Villagrasa, Pamela Celiz, X. Perez Martin, Eva Ciruelos, Sonia Pernas
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundThe CAPRICE trial was designed to specifically evaluate neoadjuvant pegylated liposomal doxorubicin (PLD) in elderly patients or in those with other cardiovascular risk factors in whom conventional doxorubicin was contraindicated. The prima
Externí odkaz:
https://doaj.org/article/2c7ae2d8c0e04340b03724c800de964a